Concerns regarding the use of antenatal betamethasone in late preterm gestation: is the evidence of potential harm being overstated?

BJOG. 2018 Jul;125(8):923-924. doi: 10.1111/1471-0528.14271. Epub 2016 Sep 5.

Authors

C Gyamfi-Bannerman¹, G Saade², S C Blackwell³

Affiliations

¹ Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Columbia University, New York, NY, USA.
² Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, University of Texas Medical Branch at Galveston, Galveston, TX, USA.
³ Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, McGovern Medical School-University of Texas at Houston, Houston, TX, USA.

PMID: 27592849
DOI: 10.1111/1471-0528.14271

No abstract available

Publication types

Comment

MeSH terms

Betamethasone*
Evidence-Based Practice
Female
Glucocorticoids
Humans
Infant, Newborn
Pregnancy
Premature Birth*

Substances

Glucocorticoids
Betamethasone